Bristol-Myers Squibb Company

Bristol-Myers Squibb Beats on EPS, Stock Up 2.61%

Bristol-Myers Squibb reported a better-than-expected EPS for the fourth quarter of 2012, which led to a positive stock reaction, with shares rising by 2.61%. The company did not provide any revenue figures or guidance, leaving some uncertainty about future performance. Investors may view the EPS beat as a sign of underlying strength, but the lack of additional details could lead to cautious sentiment moving forward.